AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
Log in

NASDAQ:SAVACassava Sciences News Headlines

$2.14
+0.03 (+1.42 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
$2.07
Now: $2.14
$2.15
50-Day Range
$2.11
MA: $5.53
$9.64
52-Week Range
$1.03
Now: $2.14
$10.95
Volume926,789 shs
Average Volume2.93 million shs
Market Capitalization$53.03 million
P/E RatioN/A
Dividend YieldN/A
Beta3.28

Headlines

Cassava Sciences (NASDAQ SAVA) News Headlines

Source:
DateHeadline
Cassava Sciences (SAVA): Let’s Shed Some Light on That CrashCassava Sciences (SAVA): Let’s Shed Some Light on That Crash
finance.yahoo.com - May 19 at 11:13 PM
Cassava Sciences (SAVA) in Focus: Stock Moves 8.5% HigherCassava Sciences (SAVA) in Focus: Stock Moves 8.5% Higher
finance.yahoo.com - May 19 at 1:12 PM
Cassava Sciences (NASDAQ:SAVA) Downgraded by HC Wainwright to "Neutral"Cassava Sciences (NASDAQ:SAVA) Downgraded by HC Wainwright to "Neutral"
www.americanbankingnews.com - May 18 at 9:53 AM
Analysts Expect Cassava Sciences Inc (NASDAQ:SAVA) to Announce ($0.06) Earnings Per ShareAnalysts Expect Cassava Sciences Inc (NASDAQ:SAVA) to Announce ($0.06) Earnings Per Share
www.americanbankingnews.com - May 16 at 6:40 PM
Zacks: Analysts Anticipate Cassava Sciences Inc (NASDAQ:SAVA) to Announce -$0.06 Earnings Per ShareZacks: Analysts Anticipate Cassava Sciences Inc (NASDAQ:SAVA) to Announce -$0.06 Earnings Per Share
www.americanbankingnews.com - May 16 at 10:12 AM
Cassava stock falls on failed Alzheimers studyCassava stock falls on failed Alzheimer's study
www.msn.com - May 15 at 11:51 PM
BRIEF-Top-Line Results From Cassavas Phase 2B Study Of Pti-125 In AlzheimerS Disease Does Not Meet Primary EndpointBRIEF-Top-Line Results From Cassava's Phase 2B Study Of Pti-125 In Alzheimer'S Disease Does Not Meet Primary Endpoint
www.reuters.com - May 15 at 11:51 PM
Cassava Sciences (NASDAQ:SAVA) Downgraded by Maxim Group to HoldCassava Sciences (NASDAQ:SAVA) Downgraded by Maxim Group to Hold
www.americanbankingnews.com - May 15 at 3:23 PM
Why Nano-Cap Biotech Cassava Is Losing 75% Of Its Market CapWhy Nano-Cap Biotech Cassava Is Losing 75% Of Its Market Cap
www.benzinga.com - May 15 at 2:25 PM
Cassava Sciences Alzheimers Drug Candidate Misses Trial EndpointCassava Sciences Alzheimer's Drug Candidate Misses Trial Endpoint
www.thestreet.com - May 15 at 2:25 PM
Cassava Sciences Alzheimer's Drug Candidate Misses Trial EndpointCassava Sciences Alzheimer's Drug Candidate Misses Trial Endpoint
finance.yahoo.com - May 15 at 2:25 PM
Cassava stock falls on failed Alzheimer's studyCassava stock falls on failed Alzheimer's study
finance.yahoo.com - May 15 at 1:49 PM
Top-line Results from a Phase 2b Study of PTI-125 in Alzheimers Disease Does Not Meet Primary EndpointTop-line Results from a Phase 2b Study of PTI-125 in Alzheimer's Disease Does Not Meet Primary Endpoint
www.benzinga.com - May 15 at 8:48 AM
Cassava Alzheimers candidate flunks mid-stage study; shares haltedCassava Alzheimer's candidate flunks mid-stage study; shares halted
seekingalpha.com - May 15 at 8:48 AM
Top-line Results from a Phase 2b Study of PTI-125 in Alzheimer’s Disease Does Not Meet Primary EndpointTop-line Results from a Phase 2b Study of PTI-125 in Alzheimer’s Disease Does Not Meet Primary Endpoint
finance.yahoo.com - May 15 at 8:48 AM
Cassava Sciences Target of Unusually High Options Trading (NASDAQ:SAVA)Cassava Sciences Target of Unusually High Options Trading (NASDAQ:SAVA)
www.americanbankingnews.com - May 11 at 2:32 PM
Cassava Sciences (SAVA) "Buy" Rating Reiterated at HC WainwrightCassava Sciences' (SAVA) "Buy" Rating Reiterated at HC Wainwright
www.americanbankingnews.com - May 8 at 7:53 AM
Cassava Sciences, Inc. (SAVA)Cassava Sciences, Inc. (SAVA)
au.finance.yahoo.com - May 8 at 2:44 AM
Cassava Sciences Reports First Quarter 2020 Financial Results and Provides Business UpdateCassava Sciences Reports First Quarter 2020 Financial Results and Provides Business Update
finance.yahoo.com - May 6 at 9:57 AM
Add Value to Your Portfolio With 5 High Earnings Yield PicksAdd Value to Your Portfolio With 5 High Earnings Yield Picks
finance.yahoo.com - May 6 at 9:57 AM
Could This Be the Medical Breakthrough for The Next DecadeCould This Be the Medical Breakthrough for The Next Decade
www.benzinga.com - May 4 at 8:33 AM
Company News for Apr 24, 2020Company News for Apr 24, 2020
finance.yahoo.com - April 24 at 12:21 PM
Cassava up 22% on new funding for Alzheimers candidateCassava up 22% on new funding for Alzheimer's candidate
seekingalpha.com - April 23 at 1:14 PM
Cassava Sciences Announces New $2.5 Million Research Grant Award from National Institutes of HealthCassava Sciences Announces New $2.5 Million Research Grant Award from National Institutes of Health
finance.yahoo.com - April 23 at 10:11 AM
Were Excited To See How Cassava Sciences (NASDAQ:SAVA) Uses Its Cash Hoard To GrowWe're Excited To See How Cassava Sciences (NASDAQ:SAVA) Uses Its Cash Hoard To Grow
finance.yahoo.com - April 13 at 5:49 PM
We're Excited To See How Cassava Sciences (NASDAQ:SAVA) Uses Its Cash Hoard To GrowWe're Excited To See How Cassava Sciences (NASDAQ:SAVA) Uses Its Cash Hoard To Grow
finance.yahoo.com - April 13 at 5:49 PM
Cassava Sciences EPS beats by $0.05Cassava Sciences EPS beats by $0.05
seekingalpha.com - March 27 at 9:25 AM
BRIEF-Cassava Sciences Announces Full-Year 2019 Financial Results And Anticipated Key Milestones For 2020BRIEF-Cassava Sciences Announces Full-Year 2019 Financial Results And Anticipated Key Milestones For 2020
www.reuters.com - March 26 at 9:02 PM
Cassava Sciences Announces Full-year 2019 Financial Results and Anticipated Key Milestones for 2020Cassava Sciences Announces Full-year 2019 Financial Results and Anticipated Key Milestones for 2020
finance.yahoo.com - March 26 at 11:02 AM
Cassava launches extension study of lead drug in AlzheimersCassava launches extension study of lead drug in Alzheimer's
seekingalpha.com - March 25 at 1:31 PM
Cassava Sciences Announces Initiation of an Open-Label Study to Evaluate PTI-125 in Patients with Alzheimer’s DiseaseCassava Sciences Announces Initiation of an Open-Label Study to Evaluate PTI-125 in Patients with Alzheimer’s Disease
finance.yahoo.com - March 25 at 8:30 AM
Stock Alert: Cassava Sciences To Report Q4 Results TodayStock Alert: Cassava Sciences To Report Q4 Results Today
www.nasdaq.com - March 23 at 8:15 AM
Cassava Sciences +11% premarket on clinical updatesCassava Sciences +11% premarket on clinical updates
seekingalpha.com - March 19 at 12:08 PM
Cassava Sciences Announces Clinical Update and Business Progress Across Neuroscience PipelineCassava Sciences Announces Clinical Update and Business Progress Across Neuroscience Pipeline
finance.yahoo.com - March 19 at 8:43 AM
Cassava Sciences IncCassava Sciences Inc
www.bloomberg.com - March 15 at 7:04 PM
What Lies Ahead for Cassava Sciences (SAVA) in Q4 Earnings?What Lies Ahead for Cassava Sciences (SAVA) in Q4 Earnings?
finance.yahoo.com - March 2 at 1:05 PM
Cassava Sciences Inc.Cassava Sciences Inc.
www.barrons.com - February 12 at 11:42 PM
Cassava Sciences Announces Phase 2a Study of PTI-125 Published in The Journal of Prevention of Alzheimer’s Disease (JPAD)Cassava Sciences Announces Phase 2a Study of PTI-125 Published in The Journal of Prevention of Alzheimer’s Disease (JPAD)
finance.yahoo.com - February 11 at 8:30 AM
Cassava Sciences Announces Completion of Patient Enrollment of a Phase 2b Study in Alzheimer’s DiseaseCassava Sciences Announces Completion of Patient Enrollment of a Phase 2b Study in Alzheimer’s Disease
finance.yahoo.com - January 28 at 8:29 AM
Cassava Sciences And The Hunt For An Alzheimers CureCassava Sciences And The Hunt For An Alzheimer's Cure
seekingalpha.com - January 19 at 12:18 PM
Cassava Sciences: Alzheimers Solution Shows Promise After Positive Phase 2a TrialCassava Sciences: Alzheimer's Solution Shows Promise After Positive Phase 2a Trial
seekingalpha.com - January 15 at 6:44 PM
Heavy Insider Buying On Cassava Sciences Pushes Up The Stock PriceHeavy Insider Buying On Cassava Sciences Pushes Up The Stock Price
seekingalpha.com - January 14 at 1:44 PM
Cassava Sciences: An Investment Opportunity With Some Volatile Periods But A Net UpsideCassava Sciences: An Investment Opportunity With Some Volatile Periods But A Net Upside
seekingalpha.com - January 14 at 1:44 PM
The Zacks Analyst Blog Highlights: Agile Therapeutics, Air Industries, Dermira, Microbot Medical and Cassava SciencesThe Zacks Analyst Blog Highlights: Agile Therapeutics, Air Industries, Dermira, Microbot Medical and Cassava Sciences
finance.yahoo.com - January 10 at 3:47 PM
Buy Multibagger Stocks as Odds of a Rally Are High in 2020Buy Multibagger Stocks as Odds of a Rally Are High in 2020
finance.yahoo.com - January 9 at 6:59 AM
20 Healthcare Stocks Moving In Tuesdays Pre-Market Session20 Healthcare Stocks Moving In Tuesday's Pre-Market Session
www.msn.com - January 7 at 4:19 PM
Are Insiders Buying Cassava Sciences, Inc. (NASDAQ:SAVA) Stock?Are Insiders Buying Cassava Sciences, Inc. (NASDAQ:SAVA) Stock?
finance.yahoo.com - January 6 at 6:30 AM
Company News For Jan 3, 2020Company News For Jan 3, 2020
finance.yahoo.com - January 3 at 4:15 PM
20 Stocks Moving in Thursdays Pre-Market Session20 Stocks Moving in Thursday's Pre-Market Session
www.msn.com - January 2 at 1:45 PM
Cassavas stock rises 33%Cassava's stock rises 33%
www.msn.com - January 2 at 1:45 PM
This page was last updated on 5/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.